SEC Form 4 · accession 0001127602-18-036011
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Dec 10, 2018
Accepted (ET)
Dec 12, 2018 · 12:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 10, 2018 | S | 199 | $127.30 | D | 294,885 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $127.315 | D | 294,785 | D | |
| Common Stock | Dec 10, 2018 | S | 200 | $127.33 | D | 294,585 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $127.34 | D | 294,485 | D | |
| Common Stock | Dec 10, 2018 | S | 500 | $127.36 | D | 293,985 | D | |
| Common Stock | Dec 10, 2018 | S | 187 | $127.37 | D | 293,798 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $127.38 | D | 293,698 | D | |
| Common Stock | Dec 10, 2018 | S | 700 | $127.40 | D | 292,998 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $127.41 | D | 292,898 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $127.43 | D | 292,798 | D | |
| Common Stock | Dec 10, 2018 | S | 200 | $127.49 | D | 292,598 | D | |
| Common Stock | Dec 10, 2018 | S | 200 | $127.54 | D | 292,398 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $127.55 | D | 292,298 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $127.56 | D | 292,198 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $127.57 | D | 292,098 | D | |
| Common Stock | Dec 10, 2018 | S | 10 | $127.59 | D | 292,088 | D | |
| Common Stock | Dec 10, 2018 | S | 10 | $127.615 | D | 292,078 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $127.65 | D | 291,978 | D | |
| Common Stock | Dec 10, 2018 | S | 200 | $127.67 | D | 291,778 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $127.76 | D | 291,678 | D | |
| Common Stock | Dec 10, 2018 | S | 118 | $127.805 | D | 291,560 | D | |
| Common Stock | Dec 10, 2018 | S | 10 | $127.81 | D | 291,550 | D | |
| Common Stock | Dec 10, 2018 | S | 34 | $127.835 | D | 291,516 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $127.845 | D | 291,416 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.